Clinical signi W cance of EphA 2 expression in squamous-cell carcinoma of the head and neck

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential gene expression profiling of laryngeal squamous cell carcinoma by laser capture microdissection and complementary DNA microarrays.

  2009cited by this paper
• EphA2 reexpression prompts invasion of melanoma cells shifting from mesenchymal to amoeboid-like motility style.

  2009cited by this paper
• EphA2 overexpression is associated with lack of hormone receptor expression and poor outcome in endometrial cancer

  2009cited by this paper
• Tumorigenesis and Neoplastic Progression Kinase-Dependent and -Independent Roles of EphA2 in the Regulation of Prostate Cancer Invasion and Metastasis

  2009cited by this paper
• Over-Expression of EphA2 and EphrinA-1 in Human Gastric Adenocarcinoma and Its Prognostic Value for Postoperative Patients

  2009cited by this paper
• Expression of the Receptor Tyrosine Kinase EphA2 Is Increased in Smokers and Predicts Poor Survival in Non–Small Cell Lung Cancer

  2009influential reference
• Eph-ephrin bidirectional signaling in physiology and disease.

  2008cited by this paper
• Cancer Statistics, 2008

  2008cited by this paper
• Involvement of EphA2 in head and neck squamous cell carcinoma: mRNA expression, loss of heterozygosity and immunohistochemical studies.

  2008cited by this paper
• EphA2 overexpression promotes ovarian cancer growth

  2008cited by this paper
• The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.

  2008cited by this paper
• Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.

  2007cited by this paper
• Expression of EphA2 and E-cadherin in colorectal cancer : correlation with cancer metastasis

  2006cited by this paper
• Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in mice.

  2006cited by this paper
• Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival

  2006cited by this paper
• A genome-wide screen reveals functional gene clusters in the cancer genome and identifies EphA2 as a mitogen in glioblastoma.

  2006influential reference
• The EphB4 Receptor-tyrosine Kinase Promotes the Migration of Melanoma Cells through Rho-mediated Actin Cytoskeleton Reorganization*

  2006cited by this paper
• Expression of EphA2 and Ephrin A-1 in Carcinoma of the Urinary Bladder

  2006cited by this paper
• A conditional feedback loop regulates Ras activity through EphA2.

  2005cited by this paper
• Global Cancer Statistics, 2002

  2005cited by this paper
• Developmental cell biology: Eph receptor signalling casts a wide net on cell behaviour

  2005cited by this paper
• Expression of EphA2 is prognostic of disease-free interval and overall survival in surgically treated patients with renal cell carcinoma.

  2005influential reference
• RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine

  2004cited by this paper
• PROGNOSTIC VALUE OF EPHA2 AND EPHRINA-1 IN SQUAMOUS CELL CERVICAL CARCINOMA

  2004cited by this paper
• EphA2 Expression Is Associated with Aggressive Features in Ovarian Carcinoma

  2004influential reference
• EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation

  2004cited by this paper
• Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival.

  2003cited by this paper
• EphA2 overexpression correlates with poor prognosis in esophageal squamous cell carcinoma

  2003cited by this paper
• Importance of vascular phenotype by basic fibroblast growth factor, and influence of the angiogenic factors basic fibroblast growth factor/fibroblast growth factor receptor-1 and ephrin-A1/EphA2 on melanoma progression.

  2002cited by this paper
• A lymph node metastatic mouse model reveals alterations of metastasis‐related gene expression in metastatic human oral carcinoma sublines selected from a poorly metastatic parental cell line

  2002influential reference
• Regulation of the EphA2 Kinase by the Low Molecular Weight Tyrosine Phosphatase Induces Transformation*

  2002cited by this paper
• c-Cbl-dependent EphA2 protein degradation is induced by ligand binding.

  2002cited by this paper
• Mechanisms and functions of eph and ephrin signalling

  2002cited by this paper
• EphA2 overexpression causes tumorigenesis of mammary epithelial cells.

  2001cited by this paper
• Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2).

  2001cited by this paper
• Eph receptors and ephrin ligands: embryogenesis to tumorigenesis

  2000cited by this paper
• E-cadherin regulates the function of the EphA2 receptor tyrosine kinase.

  1999cited by this paper
• ECK, a human EPH-related gene, maps to 1p36.1, a common region of alteration in human cancers.

  1997cited by this paper

• No citing papers are available for this paper.